Pharmacological inhibition of RIPK3 by GSK’872 accelerated the degradation of autophagosomes, induced the formation of autolysosomes, and thus alleviated tubular injury and improved renal function in sepsis-induced AKI (Li et al., 2021b). This evidence concerns the gene RIPK3 and acute kidney injury.